MedTrace Logo

Pomegranate Juice and Metabolic Syndrome

NCT02298621 · Status: COMPLETED · Phase: NA · Type: INTERVENTIONAL · Enrollment: 30

Last updated 2014-11-24

No results posted yet for this study

Summary

The effect of pomegranate juice (PJ) intake on cardiovascular risks in subject with metabolic syndrome.

Conditions

  • Metabolic Syndrome

Interventions

OTHER

pomegranate juice

Randomized clinical trial or RCT

OTHER

placebo

Randomized clinical trial or RCT

Sponsors & Collaborators

  • Urmia University of Medical Sciences

    lead OTHER

Principal Investigators

  • mohammad alizadeh · Urmia University of Medical Sciences

Study Design

Allocation
RANDOMIZED
Purpose
SUPPORTIVE_CARE
Masking
SINGLE
Model
CROSSOVER

Eligibility

Min Age
18 Years
Max Age
70 Years
Sex
ALL
Healthy Volunteers
Yes

Timeline & Regulatory

Start
2013-01-31
Primary Completion
2013-02-28
Completion
2013-02-28

Countries

  • Iran

Study Locations

More Related Trials

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT02298621 on ClinicalTrials.gov